A case of living-related kidney transplantation in Bartter's syndrome.
Bartter's syndrome is a renal tubular disorder characterized by hypokalemia, metabolic alkalosis, increased urinary excretion of potassium and prostaglandins, a relative vascular resistance to the pressor effects of exogenous angiotensin II, and hyperplasia of the juxtaglomerular apparatus. In most patients, the glomerular filtration rate is normal and chronic renal failure does not develop. We report here on a case of living-related kidney transplantation in Bartter's syndrome, in which a non-steroidal anti-inflammatory drug is suspected to be the cause of the end-stage renal disease.
Kim
J Y
JY
Department of Internal Medicine, Inha University College of Medicine, Inchon, Seoul, Korea.
Kim
G A
GA
Song
J H
JH
Lee
S W
SW
Han
J Y
JY
Lee
J S
JS
Kim
M J
MJ
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001477:Bartter Syndrome / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000139:chemically induced* / Q000601:surgery*; D016030:Kidney Transplantation; D019520:Living Donors; D008297:Male
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin